MSP Recovery Downgraded to OTC Expert Market Due to Unfiled Financials
MSPR sits 81% above its 52-week low of $0.011.
Summary
MSP Recovery's stock will be downgraded to the OTC Expert Market on July 17, 2026, due to its failure to file required financial reports, severely limiting trading access for investors.
Key Events · Corporate Governance and Compliance · MSPR
-
Downgrade to OTC Expert Market
Effective July 17, 2026, the company's Class A common stock and publicly traded warrants will move from the OTC Pink Limited Information tier to the OTC Expert Market. This market is only available for unsolicited quotes from broker-dealers to sophisticated investors, severely restricting trading access for most retail investors.
-
Failure to File Financial Reports
The downgrade is a direct result of the company's failure to file its Annual Report on Form 10-K for 2025 and Quarterly Report on Form 10-Q for Q1 2026. The company does not expect to regain compliance by the July 17, 2026 deadline.
-
Ongoing Dilutive Financing
The prospectus supplement updates an existing Standby Equity Purchase Agreement (SEPA) with Yorkville, allowing for the sale of up to $250 million in Class A Common Stock at a discount to market price. The company also has convertible notes with Yorkville, which have seen their conversion floor price repeatedly reduced from $224.00 to $0.50 per share, indicating significant stock price decline and ongoing dilution.
-
Previous Nasdaq Delisting
The company's Class A common stock ceased trading on the Nasdaq Capital Market on December 22, 2025, and began trading on the OTCQB, leading to an event of default under its convertible notes, which Yorkville temporarily extended.
Analysis · MSPR · Technology
MSP Recovery faces a critical blow as its securities are set to move to the OTC Expert Market, effectively cutting off most retail investor access. This downgrade is a direct consequence of the company's failure to file its annual and quarterly financial reports, signaling severe operational and compliance issues. The filing also highlights the company's continued reliance on highly dilutive financing through its Standby Equity Purchase Agreement with Yorkville, which has seen repeated concessions and floor price reductions as the stock price has plummeted. This combination of a major market downgrade and ongoing desperate financing efforts indicates a company in deep distress with significant transparency and liquidity challenges.
At the time of this filing, MSPR was trading at $0.02 on OTC in the Technology sector, with a market capitalization of approximately $283.6K. The 52-week trading range was $0.01 to $59.29. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.